113 related articles for article (PubMed ID: 37949233)
1. Molecular detection of antimalarial resistance in Plasmodium vivax isolates from a tertiary care setting in Puducherry.
Stanley P; Rajkumari N; Sivaradjy M
Indian J Med Microbiol; 2024; 47():100496. PubMed ID: 37949233
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
[TBL] [Abstract][Full Text] [Related]
3. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
[TBL] [Abstract][Full Text] [Related]
4. Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China.
Huang B; Huang S; Su XZ; Tong X; Yan J; Li H; Lu F
Malar J; 2014 Sep; 13():346. PubMed ID: 25179752
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Barnadas C; Tichit M; Bouchier C; Ratsimbasoa A; Randrianasolo L; Raherinjafy R; Jahevitra M; Picot S; Ménard D
Malar J; 2008 Feb; 7():35. PubMed ID: 18302746
[TBL] [Abstract][Full Text] [Related]
6. Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.
Mint Lekweiry K; Ould Mohamed Salem Boukhary A; Gaillard T; Wurtz N; Bogreau H; Hafid JE; Trape JF; Bouchiba H; Ould Ahmedou Salem MS; Pradines B; Rogier C; Basco LK; Briolant S
J Antimicrob Chemother; 2012 Feb; 67(2):367-74. PubMed ID: 22086859
[TBL] [Abstract][Full Text] [Related]
7. Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.
Zhao Y; Wang L; Soe MT; Aung PL; Wei H; Liu Z; Ma T; Huang Y; Menezes LJ; Wang Q; Kyaw MP; Nyunt MH; Cui L; Cao Y
Malar J; 2020 Aug; 19(1):281. PubMed ID: 32758218
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Rakmark K; Awab GR; Duanguppama J; Boonyuen U; Dondorp AM; Imwong M
Malar J; 2020 Jul; 19(1):251. PubMed ID: 32664924
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China-Myanmar border during 2008‒2017.
Wang Z; Wei C; Pan Y; Wang Z; Ji X; Chen Q; Zhang L; Wang Z; Wang H
Infect Dis Poverty; 2022 Apr; 11(1):43. PubMed ID: 35462549
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
[TBL] [Abstract][Full Text] [Related]
11. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Infect Genet Evol; 2012 Jan; 12(1):38-44. PubMed ID: 22020253
[TBL] [Abstract][Full Text] [Related]
12. Molecular evaluation of pvdhfr and pvmdr-1 mutants in Plasmodium vivax isolates after treatment with sulfadoxine/pyrimethamine and chloroquine in Iran during 2001-2016.
Parsaei M; Raeisi A; Spotin A; Shahbazi A; Mahami-Oskouei M; Hazratian T; Khorashad AS; Zaman J; Bazmani A; Sarafraz S
Infect Genet Evol; 2018 Oct; 64():70-75. PubMed ID: 29929007
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.
Tantiamornkul K; Pumpaibool T; Piriyapongsa J; Culleton R; Lek-Uthai U
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):229-237. PubMed ID: 29677637
[TBL] [Abstract][Full Text] [Related]
15. Presence of novel triple mutations in the pvdhfr from Plasmodium vivax in Mangaluru city area in the southwestern coastal region of India.
Joy S; Ghosh SK; Achur RN; Gowda DC; Surolia N
Malar J; 2018 Apr; 17(1):167. PubMed ID: 29661235
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan.
Raza A; Ghanchi NK; Khan MS; Beg MA
Malar J; 2013 Jul; 12():261. PubMed ID: 23890361
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported
Bansal D; Acharya A; Bharti PK; Abdelraheem MH; Elmalik A; Abosalah S; Khan FY; ElKhalifa M; Kaur H; Mohapatra PK; Sehgal R; Idris MA; Mahanta J; Singh N; Babiker HA; Sultan AA
Am J Trop Med Hyg; 2017 Dec; 97(6):1797-1803. PubMed ID: 29016333
[No Abstract] [Full Text] [Related]
18. Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines.
Bareng AP; Espino FE; Chaijaroenkul W; Na-Bangchang K
Acta Trop; 2018 Apr; 180():81-87. PubMed ID: 29352991
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan.
Nadeem MF; Khattak AA; Zeeshan N; Zahid H; Awan UA; Yaqoob A; Ashraf NM; Gul S; Alam S; Ahmed W
Rev Inst Med Trop Sao Paulo; 2021; 63():e59. PubMed ID: 34407160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
